edaravone and ozagrel
edaravone has been researched along with ozagrel in 9 studies
Research
Studies (9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hashimoto, N; Takabatake, Y; Tsuchiya, Y; Uno, E; Wakamatsu, K; Yamazaki, N | 1 |
| Echizen, H; Oishi, K; Uchida, M; Yamaguchi, T | 1 |
| Ichikawa, K; Imamura, T; Kiguchi, S; Kobayashi, K; Kojima, M; Yamazaki, Y | 1 |
| Shinohara, Y | 1 |
| Kobayashi, S; Saito, I; Shinohara, Y; Uchiyama, S | 1 |
| Matsubara, S; Nagahiro, S; Sasaki, I; Yamasaki, H | 1 |
| Inoue, S; Shinohara, Y | 1 |
| Adachi, H; Ishibashi, A; Yoshitake, Y | 1 |
| Chen, X; Ma, B; Shi, J; Sun, H; Yang, B | 1 |
Reviews
2 review(s) available for edaravone and ozagrel
| Article | Year |
|---|---|
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
Efficacy and safety of therapies for acute ischemic stroke in China: a network meta-analysis of 13289 patients from 145 randomized controlled trials.
Topics: Aged; Antipyrine; Bayes Theorem; China; Coagulants; Drug Therapy, Combination; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Humans; Kallikreins; Methacrylates; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2014 |
Trials
1 trial(s) available for edaravone and ozagrel
| Article | Year |
|---|---|
Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Topics: Aged; Aged, 80 and over; Antipyrine; Edaravone; Female; Free Radical Scavengers; Humans; Japan; Male; Methacrylates; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome | 2009 |
Other Studies
6 other study(ies) available for edaravone and ozagrel
| Article | Year |
|---|---|
[The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction].
Topics: Aged; Antipyrine; Cerebral Infarction; Drug Therapy, Combination; Edaravone; Female; Fibrinolytic Agents; Free Radical Scavengers; Humans; Male; Methacrylates; Middle Aged; Treatment Outcome | 2003 |
Edaravone, a radical scavenger, may enhance or produce antiproliferative effects of fluvastatin, amlodipine, ozagrel, GF109203X and Y27632 on cultured basilar artery smooth muscle cells.
Topics: Amides; Amlodipine; Animals; Antipyrine; Arteriosclerosis; Basilar Artery; Cell Division; Cell Survival; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; Edaravone; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Indoles; Maleimides; Methacrylates; Muscle, Smooth, Vascular; Pyridines; Reactive Oxygen Species; Signal Transduction; Tetrazolium Salts; Thiazoles | 2003 |
Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger.
Topics: Animals; Antipyrine; Edaravone; Enzyme Inhibitors; Free Radical Scavengers; Infarction, Middle Cerebral Artery; Male; Methacrylates; Middle Cerebral Artery; Optic Chiasm; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thrombosis; Thromboxane-A Synthase | 2003 |
Retinal artery embolization during carotid angioplasty and carotid artery stenting: case report.
Topics: Aged; Angioplasty, Balloon; Anticoagulants; Antipyrine; Aspirin; Carotid Artery, External; Carotid Stenosis; Cerebral Infarction; Combined Modality Therapy; Drug Therapy, Combination; Edaravone; Embolism; Heparin; Humans; Hyperbaric Oxygenation; Intraoperative Complications; Male; Methacrylates; Ophthalmic Artery; Recurrence; Retinal Artery Occlusion; Stents; Ticlopidine | 2009 |
Cost-effectiveness analysis of the neuroprotective agent edaravone for noncardioembolic cerebral infarction.
Topics: Aged; Antipyrine; Cerebral Infarction; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Edaravone; Female; Free Radical Scavengers; Hospital Costs; Humans; Intracranial Embolism; Male; Markov Chains; Methacrylates; Models, Economic; Neuroprotective Agents; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Secondary Prevention; Time Factors; Treatment Outcome | 2013 |
Investigation of effect of edaravone on ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Antipyrine; Arginine; Edaravone; Female; Free Radical Scavengers; Humans; Ischemia; Male; Methacrylates; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Factors; Stroke; Sulfonamides; Young Adult | 2013 |